GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Cyclically Adjusted PB Ratio

Porton Pharma Solutions (SZSE:300363) Cyclically Adjusted PB Ratio : 2.26 (As of Jun. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Cyclically Adjusted PB Ratio?

As of today (2024-06-21), Porton Pharma Solutions's current share price is ¥13.19. Porton Pharma Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥5.84. Porton Pharma Solutions's Cyclically Adjusted PB Ratio for today is 2.26.

The historical rank and industry rank for Porton Pharma Solutions's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300363' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.25   Med: 8.11   Max: 24.47
Current: 2.25

During the past years, Porton Pharma Solutions's highest Cyclically Adjusted PB Ratio was 24.47. The lowest was 2.25. And the median was 8.11.

SZSE:300363's Cyclically Adjusted PB Ratio is ranked worse than
55.91% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs SZSE:300363: 2.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Porton Pharma Solutions's adjusted book value per share data for the three months ended in Mar. 2024 was ¥10.400. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥5.84 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Porton Pharma Solutions Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Porton Pharma Solutions's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Cyclically Adjusted PB Ratio Chart

Porton Pharma Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 23.35 8.44 4.48

Porton Pharma Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.40 5.66 5.23 4.48 3.06

Competitive Comparison of Porton Pharma Solutions's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Porton Pharma Solutions's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's Cyclically Adjusted PB Ratio falls into.



Porton Pharma Solutions Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Porton Pharma Solutions's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=13.19/5.84
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Porton Pharma Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Porton Pharma Solutions's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.4/115.2271*115.2271
=10.400

Current CPI (Mar. 2024) = 115.2271.

Porton Pharma Solutions Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.795 98.200 2.106
201409 1.846 98.900 2.151
201412 1.984 99.000 2.309
201503 2.013 99.900 2.322
201506 2.065 99.500 2.391
201509 2.471 100.500 2.833
201512 2.655 100.600 3.041
201603 2.705 102.200 3.050
201606 2.817 101.400 3.201
201609 2.885 102.400 3.246
201612 3.019 102.600 3.391
201703 3.094 103.200 3.455
201706 3.136 103.100 3.505
201709 3.163 104.100 3.501
201712 3.239 104.500 3.571
201803 3.283 105.300 3.593
201806 5.251 104.900 5.768
201809 5.303 106.600 5.732
201812 5.312 106.500 5.747
201903 5.338 107.700 5.711
201906 5.389 107.700 5.766
201909 5.530 109.800 5.803
201912 5.650 111.200 5.855
202003 5.750 112.300 5.900
202006 5.812 110.400 6.066
202009 6.067 111.700 6.259
202012 6.249 111.500 6.458
202103 6.402 112.662 6.548
202106 6.531 111.769 6.733
202109 6.932 112.215 7.118
202112 7.314 113.108 7.451
202203 8.057 114.335 8.120
202206 9.417 114.558 9.472
202209 10.195 115.339 10.185
202212 10.994 115.116 11.005
202303 11.606 115.116 11.617
202306 10.728 114.558 10.791
202309 10.912 115.339 10.901
202312 10.622 114.781 10.663
202403 10.400 115.227 10.400

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Porton Pharma Solutions  (SZSE:300363) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Porton Pharma Solutions Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions (SZSE:300363) Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines